-
1
-
-
2142781633
-
"Experience in the use of dopamine receptor agonists in the out-patient treatment of Parkinson's disease"
-
A. N. Boiko, T. T. Batysheva, E. S. Chikina, et al., "Experience in the use of dopamine receptor agonists in the out-patient treatment of Parkinson's disease," Zh. Nevrol. Psikhiat., 103, No. 9, 54-58 (2003).
-
(2003)
Zh. Nevrol. Psikhiat.
, vol.103
, Issue.9
, pp. 54-58
-
-
Boiko, A.N.1
Batysheva, T.T.2
Chikina, E.S.3
-
2
-
-
18244384502
-
"Use of Tremonorm in Parkinson's disease: Experience of the out-patient neurological service of the Moscow City Health System"
-
A. N. Boiko, T. T. Batysheva, E. S. Chikina, et al., "Use of Tremonorm in Parkinson's disease: Experience of the out-patient neurological service of the Moscow City Health System," Zh. Nevrol. Psikhiat., 104, No. 12, 23-28 (2004).
-
(2004)
Zh. Nevrol. Psikhiat.
, vol.104
, Issue.12
, pp. 23-28
-
-
Boiko, A.N.1
Batysheva, T.T.2
Chikina, E.S.3
-
3
-
-
56249092912
-
"Efficacy of PK-Merz in Parkinson's disease in out-patient practice"
-
A. N. Boiko, T. T. Batysheva, E. S. Chikina, et al., "Efficacy of PK-Merz in Parkinson's disease in out-patient practice," Lech. Nerv. Bolezn., 2, 23-27 (2005).
-
(2005)
Lech. Nerv. Bolezn.
, vol.2
, pp. 23-27
-
-
Boiko, A.N.1
Batysheva, T.T.2
Chikina, E.S.3
-
4
-
-
0004100625
-
-
[in Russian], Medpress, Moscow
-
V. L. Golubev, Ya. I. Levin, and A. M. Vein, Parkinson's disease and Parkinson's Syndrome [in Russian], Medpress, Moscow (1999).
-
(1999)
Parkinson's Disease and Parkinson's Syndrome
-
-
Golubev, V.L.1
Levin, Ya.I.2
Vein, A.M.3
-
5
-
-
56249107826
-
"New possibilities in the treatment of Parkinson's disease with Stalevo (levodopa/carbidopa/entacapone)"
-
V. L. Golubev and A. A. Palipovich, "New possibilities in the treatment of Parkinson's disease with Stalevo (levodopa/carbidopa/ entacapone)," Lech. Nerv. Bolezn., 1, 1-11 (2006).
-
(2006)
Lech. Nerv. Bolezn.
, vol.1
, pp. 1-11
-
-
Golubev, V.L.1
Palipovich, A.A.2
-
6
-
-
56249110726
-
"Development of motor fluctuations in patients with different stages of Parkinson's disease"
-
O. S. Levin, "Development of motor fluctuations in patients with different stages of Parkinson's disease," Atmosfera (Nerv. Bolezn., 1, 10-16 (2005).
-
(2005)
Atmosfera Nerv. Bolezn.
, vol.1
, pp. 10-16
-
-
Levin, O.S.1
-
8
-
-
56249136063
-
"Use of catechol-O-methyltransferase (COMT) inhibitors in the treatment of the late stages of Parkinson's disease"
-
N. V. Fedorova, O. V. Krivonos, I. P. Chigir', et al., "Use of catechol-O-methyltransferase (COMT) inhibitors in the treatment of the late stages of Parkinson's disease," Kreml. Med., 2, 66-72 (2001).
-
(2001)
Kreml. Med.
, vol.2
, pp. 66-72
-
-
Fedorova, N.V.1
Krivonos, O.V.2
Chigir', I.P.3
-
9
-
-
69149103832
-
"A new-generation levodopa preparation "Stalevo (levodopa/ carbidopa/entacapone), in the treatment of Parkinson's disease"
-
N. V. Fedorova, O. S. Levin, I. G. Smolentseva, et al., "A new-generation levodopa preparation " Stalevo (levodopa/carbidopa/ entacapone), in the treatment of Parkinson's disease," Zh. Nevrol. Psikhiat., 9, 39-46 (2006).
-
(2006)
Zh. Nevrol. Psikhiat.
, vol.9
, pp. 39-46
-
-
Fedorova, N.V.1
Levin, O.S.2
Smolentseva, I.G.3
-
10
-
-
85050179907
-
-
[in Russian], Medpress-Inform, Moscow
-
V. N. Shtok, and N. V. Fedorova, Parkinson's disease. Extrapyramidal Disorders. Handbook for Diagnosis and Treatment [in Russian], Medpress-Inform, Moscow (2002), pp. 87-124.
-
(2002)
Parkinson's Disease. Extrapyramidal Disorders. Handbook for Diagnosis and Treatment
, pp. 87-124
-
-
Shtok, V.N.1
Fedorova, N.V.2
-
11
-
-
0041704637
-
"Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease. A randomized, placebo-controlled, double-blind six-month study"
-
the UK-Irish Entacapone study group
-
D. Brooks, H. Sagar, and the UK-Irish Entacapone study group, "Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease. A randomized, placebo-controlled, double-blind six-month study," J. Neurol. Neurosurg. Psychiat., 74, 1064-1072 (2003).
-
(2003)
J. Neurol. Neurosurg. Psychiat.
, vol.74
, pp. 1064-1072
-
-
Brooks, D.1
Sagar, H.2
-
12
-
-
22744453722
-
"NC-INIT Study Group. Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment"
-
D. Brooks, Y. Agid, K. Eggert, et al., "NC-INIT Study Group. Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment," Eur. Neurol., 53, No. 4, 197-202 (2005).
-
(2005)
Eur. Neurol.
, vol.53
, Issue.4
, pp. 197-202
-
-
Brooks, D.1
Agid, Y.2
Eggert, K.3
-
13
-
-
0347092046
-
"Avoidance of dyskinesia: Preclinical evidence for continuous dopaminergic stimulation"
-
P. Jenner, "Avoidance of dyskinesia: Preclinical evidence for continuous dopaminergic stimulation," Neurology, 62, Supplement 1, 47-55 (2004).
-
(2004)
Neurology
, vol.62
, Issue.SUPPL. 1
, pp. 47-55
-
-
Jenner, P.1
-
14
-
-
33645540098
-
"Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels"
-
T. Müller, C. Erdmann, S. Muhlack, et al., "Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels," Mov. Dis., 21, No. 3, 332-336 (2006).
-
(2006)
Mov. Dis.
, vol.21
, Issue.3
, pp. 332-336
-
-
Müller, T.1
Erdmann, C.2
Muhlack, S.3
-
15
-
-
12544252127
-
"Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease"
-
D. Nyholm, A. I. Nilsson Remahl, N. Disdar, et al., "Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease," Neurology, 64, No. 2, 216-223 (2005).
-
(2005)
Neurology
, vol.64
, Issue.2
, pp. 216-223
-
-
Nyholm, D.1
Nilsson Remahl, A.I.2
Disdar, N.3
-
16
-
-
5344247928
-
"Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease"
-
C. W. Olanow, K. Kieburtz, M. Stern, et al., "Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease," Arch. Neurol., 61, No. 10, 1563-1568 (2004).
-
(2004)
Arch. Neurol.
, vol.61
, Issue.10
, pp. 1563-1568
-
-
Olanow, C.W.1
Kieburtz, K.2
Stern, M.3
-
17
-
-
0347092036
-
"COMT inhibitors in Parkinson's disease: Can they prevent and/or reverse levodopa-induced motor complications?"
-
C. W. Olanow and F. Stocchi, "COMT inhibitors in Parkinson's disease: Can they prevent and/or reverse levodopa-induced motor complications?" Neurology, 62, Supplement 1, 72-81 (2004).
-
(2004)
Neurology
, vol.62
, Issue.SUPPL. 1
, pp. 72-81
-
-
Olanow, C.W.1
Stocchi, F.2
-
18
-
-
0030882893
-
"Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: Pharmacokinetic and quality-of-life measures"
-
R. Pahwa, K. Lyons, D. McGuire, et al., "Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: Pharmacokinetic and quality-of-life measures," Mov. Dis., 12, No. 5, 677-681 (1997).
-
(1997)
Mov. Dis.
, vol.12
, Issue.5
, pp. 677-681
-
-
Pahwa, R.1
Lyons, K.2
McGuire, D.3
-
19
-
-
0346576032
-
"Levodopa in Parkinson's Disease: Mechanisms of action and pathophysiology of late failure"
-
in: J. J. Jankovic and E. Tolosa (eds.)
-
W. Poewe and G. Wenning, "Levodopa in Parkinson's Disease: mechanisms of action and pathophysiology of late failure," in: Parkinson's Disease, Movement Disorders, J. J. Jankovic and E. Tolosa (eds.) (2002), pp. 104-115.
-
(2002)
Parkinson's Disease, Movement Disorders
, pp. 104-115
-
-
Poewe, W.1
Wenning, G.2
-
20
-
-
0036113588
-
"Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: A 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)"
-
W. H. Poewe, G. Deuschl, A. Gardin, et al., "Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: A 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)," Acta Neurol. Scand., 105, 245-255 (2002).
-
(2002)
Acta Neurol. Scand.
, vol.105
, pp. 245-255
-
-
Poewe, W.H.1
Deuschl, G.2
Gardin, A.3
-
21
-
-
33644824423
-
"Timing of treatment initiation in Parkinson's disease: A need for reappraisal"
-
A. H. Schapiro and J. Obeso, "Timing of treatment initiation in Parkinson's disease: A need for reappraisal," Ann. Neurol., 59, No. 3, 559-562 (2006).
-
(2006)
Ann. Neurol.
, vol.59
, Issue.3
, pp. 559-562
-
-
Schapiro, A.H.1
Obeso, J.2
-
22
-
-
19344378940
-
"Entacapone in the treatment of Parkinson's disease"
-
A. Schrag, "Entacapone in the treatment of Parkinson's disease," Lancet. Neurol., 4, No. 6, 366-370 (2005).
-
(2005)
Lancet. Neurol.
, vol.4
, Issue.6
, pp. 366-370
-
-
Schrag, A.1
|